GlassScriptPhysician profile
Hillary Hoppe
NPI 1720630049
$5,770.65
in general payments reported to CMS, 2019-2025
49 companies · $2,207 in 2025
The $2,207 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $369 · 2022: $960 · 2023: $1,161 · 2024: $1,074 · 2025: $2,207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,342 · Education: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,342.17 |
| Education | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $1,322.39 | 2024-2025 | Gemtesa, Orgovyx |
| Novo Nordisk INC | $554.13 | 2021-2024 | Rybelsus, Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $404.98 | 2021-2024 | Jardiance, Ofev |
| Abbvie INC. | $308.80 | 2022-2025 | |
| Janssen Biotech, INC. | $291.79 | 2024-2025 | Erleada, Balversa, Akeega |
| Organon LLC | $270.32 | 2021-2024 | Nexplanon |
| Myriad Genetic Laboratories, INC. | $219.82 | 2023-2025 | Myrisk, Prolaris |
| Intuitive Surgical, INC. | $198.10 | 2023-2024 | Davinci Xi |
| Inari Medical, INC. | $184.67 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $177.26 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $156.59 | 2023 | |
| Procept Biorobotics Corporation | $154.29 | 2025 | |
| Janssen Scientific Affairs, LLC | $145.94 | 2025 | Erleada |
| Astellas Pharma Global Development | $131.55 | 2025 | Xtandi |
| Otsuka America Pharmaceutical, INC. | $87.65 | 2021-2022 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hillary Hoppe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.